| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0041 | 1 |